The accrual of brain focal pathology is considered a good substrate of disability in relapsing-remitting multiple sclerosis (RRMS). However, knowledge on long-term lesion evolution and its relationship with disability progression is poor.The objective of this paper is to evaluate in RRMS the long-term clinical relevance of brain lesion evolution.In 58 RRMS patients we acquired, using the same scanner and protocol, brain magnetic resonance imaging (MRI) at baseline and 10\ub10.5 years later. MRI data were correlated with disability changes as measured by the Expanded Disability Status Scale (EDSS).The annualized 10-year lesion volume (LV) growth was +0.25\ub10.5 cm(3) (+6.7\ub18.7\%) for T2-weighted (T2-W) lesions and +0.20\ub10.31 cm(3) (+1...
BACKGROUND AND OBJECTIVES: We evaluated clinical and conventional MRI features of a large population...
Background: Slowly expanding lesions (SELs) are MRI markers of chronic active lesions in multiple sc...
Objective To evaluate the extent to which treatment effect on brain atrophy is able to mediate, at t...
BACKGROUND: The accrual of brain focal pathology is considered a good substrate of disability in re...
Objective To determine whether brain atrophy and lesion volumes predict subsequent 10 year clinical ...
Clinically isolated syndromes (CIS), such as optic neuritis, brainstem or spinal cord syndromes are ...
Abstract OBJECTIVE: We assessed the occurrence, extent, and frequency of formation of cortical lesio...
Clinically isolated syndromes (CIS), such as optic neuritis, brainstemor spinal cord syndromes are f...
Wybrecht, Delphine Reuter, Francoise Zaaraoui, Wafaa Faivre, Anthony Crespy, Lydie Rico, Audrey Mali...
BACKGROUND: Conventional MRI lesion measures modestly predict long term disability in some clinicall...
OBJECTIVES: To explore the relationship between slowly expanding lesions (SELs) on MRI and disabilit...
The clinical course of relapse-onset multiple sclerosis is highly variable. Demographic factors, cli...
Background and purposeBrain MRI-derived lesions and atrophy are related to multiple sclerosis (MS) d...
Multiple sclerosis is a long-term disease that evolves over a period of 30 to 40 years with progress...
Abstract BACKGROUND AND OBJECTIVES: We evaluated clinical and conventional MRI features of a large p...
BACKGROUND AND OBJECTIVES: We evaluated clinical and conventional MRI features of a large population...
Background: Slowly expanding lesions (SELs) are MRI markers of chronic active lesions in multiple sc...
Objective To evaluate the extent to which treatment effect on brain atrophy is able to mediate, at t...
BACKGROUND: The accrual of brain focal pathology is considered a good substrate of disability in re...
Objective To determine whether brain atrophy and lesion volumes predict subsequent 10 year clinical ...
Clinically isolated syndromes (CIS), such as optic neuritis, brainstem or spinal cord syndromes are ...
Abstract OBJECTIVE: We assessed the occurrence, extent, and frequency of formation of cortical lesio...
Clinically isolated syndromes (CIS), such as optic neuritis, brainstemor spinal cord syndromes are f...
Wybrecht, Delphine Reuter, Francoise Zaaraoui, Wafaa Faivre, Anthony Crespy, Lydie Rico, Audrey Mali...
BACKGROUND: Conventional MRI lesion measures modestly predict long term disability in some clinicall...
OBJECTIVES: To explore the relationship between slowly expanding lesions (SELs) on MRI and disabilit...
The clinical course of relapse-onset multiple sclerosis is highly variable. Demographic factors, cli...
Background and purposeBrain MRI-derived lesions and atrophy are related to multiple sclerosis (MS) d...
Multiple sclerosis is a long-term disease that evolves over a period of 30 to 40 years with progress...
Abstract BACKGROUND AND OBJECTIVES: We evaluated clinical and conventional MRI features of a large p...
BACKGROUND AND OBJECTIVES: We evaluated clinical and conventional MRI features of a large population...
Background: Slowly expanding lesions (SELs) are MRI markers of chronic active lesions in multiple sc...
Objective To evaluate the extent to which treatment effect on brain atrophy is able to mediate, at t...